Market Overview

UPDATE: Jefferies Raises PT on Cerner Corporation on Solid 4Q Bookings

Share:
Related CERN
Cerner to Replace Department of Defense's Anatomic Pathology Laboratory Information System
Healthcare IT Investors: Oppenheimer Just Made Some Waves
Leidos wins $4.34B military healthcare records contract (Seeking Alpha)

In a report published Wednesday, Jefferies reiterated its Buy rating on Cerner Corporation (NASDAQ: CERN), and raised its price target from $82.00 to $97.00.

Jefferies noted, “Bookings were the highlight of 4Q at >$1B and above expectations. 1Q13 guidance sets the stage for robust growth this year. 4Q12 earnings were solidly in line, after adjusting for two below-the-line items. Margin improvement should accelerate in 2013 as the impact of device re-sales moderates. Cerner's industry-leading commitment to R&D positions it well to continue winning market share from its competitors.”

Cerner Corporation closed on Tuesday at $83.60.

Latest Ratings for CERN

DateFirmActionFromTo
Jun 2015OppenheimerInitiates Coverage onOutperform
Apr 2015SunTrust Robinson HumphreyDowngradesBuyNeutral
Apr 2015BarclaysMaintainsBuy

View More Analyst Ratings for CERN
View the Latest Analyst Ratings

Posted-In: JefferiesAnalyst Color Price Target Analyst Ratings

 

Related Articles (CERN)

Get Benzinga's Newsletters